Experimental drug RK-33 shows promise in treating breast cancer bone metastasis

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.

Understanding postural tachycardia syndrome in cardiovascular care

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Postural tachycardia syndrome (POTS) is a chronic autonomic disorder characterized by excessive heart rate

February 20, 2024

Vertex pain drug results met with measured optimism — and questions — by observers and experts

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief.

January 30, 2024

UW research contradicts Musk’s vision of high-resolution implants

Elon Musk recently declared on X that Blindsight, a cortical implant to restore vision, would have low resolution at first “but may ultimately exceed normal

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.